| Literature DB >> 35956753 |
Jie Yang1, Jie Che1, Xin Jiang1, Yangchun Fan1, Daojiang Gao1, Jian Bi1, Zhanglei Ning1.
Abstract
As an important biomarker in urine, the level of uric acid is of importance for human health. In this work, a Cu(II) functionalized metal-organic framework (Cu2+@Tb-MOFs) is designed and developed as a novel fluorescence probe for wide-range uric acid detection in human urine. The study shows that this fluorescence platform demonstrated excellent pH-independent stability, high water tolerance, and good thermal stability. Based on the strong interaction between metal ions and uric acid, the designed Cu2+@Tb-MOFs can be employed as efficient turn-on fluorescent probes for the detection of uric acid with wide detection range (0~104 µM) and high sensitivity (LOD = 0.65 µM). This probe also demonstrates an anti-interference property, as other species coexisted, and the possibility for recycling. The sensing mechanisms are further discussed at length. More importantly, we experimentally constructed a molecular logic gate operation based on this fluorescence probe for intelligent detection of uric acid. These results suggest the Cu(II) functionalized metal-organic framework can act as a prominent candidate for personalized monitoring of the concentration of uric acid in the human urine system.Entities:
Keywords: detection; logic gate; metal–organic frameworks; probe; uric acid
Mesh:
Substances:
Year: 2022 PMID: 35956753 PMCID: PMC9369708 DOI: 10.3390/molecules27154803
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Scheme 1Schematic diagram of UA detection and application.
Figure 1(a) PXRD patterns of the reported Tb-MOFs, the synthetic crystalline Tb-MOFs and Cu2+@Tb-MOFs samples; (b) SEM image and (c) EDX of Cu2+@Tb-MOFs samples.
Figure 2(a)The emission spectra of Cu2+@Tb-MOFs sample materials immersed in various urine composition solutions (the inset is 2D-histogram based on the intensity of 5D4→7F5 transition of Tb3+ in Cu2+@Tb-MOFs toward various urine chemicals, λex = 337 nm); (b) The fluorescence intensity of Cu2+@Tb-MOFs in the presence of other components in urine (green bars), and the subsequent addition of UA (orange bars); (c) The linear relationship the fluorescence intensity and the concentration of UA; (d) Comparison of Cu2+@Tb-MOFs test paper for uric acid recognition under light (d-1) and UV (d-2) irradiation.
The performance of different probes to detect UA.
| Probe | Work Range (μM) | LOD (μM) | Ref. |
|---|---|---|---|
| Eu-BDC@FM | 0~200 | 0.6 | [ |
| MBP-SO3@Nafion | 30~3000 | 11.3 | [ |
| CD-MONT-2 | 1.5~9.1 | 4.3 | [ |
| Hf-UiO-66-Py | 0~30 | 1.4 | [ |
| Eu-TDA | 0~327 | 0.689 | [ |
| MOF-235 | 10~90 | 3.46 | [ |
| Cu2+@MIL-91(Al:Eu) | 0~1200 | 1.6 | [ |
| URICASE and HRP@HP-DUT-5 | 5~100 | 0.8 | [ |
| PCN-222(Fe) | 10~800 | 3.5 | [ |
| Cu2+@Tb-MOFs | 0~104 | 0.65 | This work |
Figure 3(a) PXRD pattern of Cu2+@Tb-MOFs and UA/Cu2+@Tb-MOFs; (b) Luminescence decay curve of Tb-MOFs, Cu2+@Tb-MOFs and UA/Cu2+@Tb-MOFs at 545 nm.
Figure 4(a) The XPS spectra for Tb-MOFs, Cu2+@Tb-MOFs, UA/Cu2+@Tb-MOFs; (b) The XPS peaks of Cu2+ in Cu2+@Tb-MOFs samples; (c) The XPS peaks of Cu2+ in UA/Cu2+@Tb-MOFs samples; (d) The XPS peaks of N in UA/Cu2+@Tb-MOFs samples.
Figure 5(a) Electronic equivalent circuitry of the logic gate; (b) The truth table of the logic gate; (c) Emission spectra of the logic gates (the inset is the relative emission intensity at 545 nm).